FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Group",
  "id": "172480",
  "meta": {
    "versionId": "9",
    "lastUpdated": "2025-09-13T11:06:30.005Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/outcome-definition"
    ]
  },
  "language": "en",
  "text": {
    "status": "empty",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
      "valueMarkdown": "OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 172480. Revised 2025-09-13. Available at: https://fevir.net/resources/Group/172480. Computable resource at: https://fevir.net/resources/Group/172480#json."
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail": {
        "name": "Brian S. Alper"
      }
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "url": "https://fevir.net/resources/Group/172480",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "172480",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "name": "OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control",
  "title": "OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control",
  "status": "active",
  "publisher": "Computable Publishing LLC",
  "contact": [
    {
      "telecom": [
        {
          "system": "email",
          "value": "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description": "The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years",
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "membership": "conceptual",
  "combinationMethod": "all-of",
  "characteristic": [
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "59261-8",
            "display": "Hemoglobin A1c/Hemoglobin.total standardized per IFCC-RMP for CDT in Blood"
          }
        ]
      },
      "valueQuantity": {
        "value": 7,
        "comparator": "<",
        "unit": "%",
        "system": "http://unitsofmeasure.org",
        "code": "%"
      },
      "exclude": false,
      "description": "hemoglobin A1c less than 7.0%",
      "timing": [
        {
          "contextCode": {
            "coding": [
              {
                "system": "http://snomed.info/sct",
                "code": "709491003",
                "display": "Enrollment in clinical trial"
              }
            ]
          },
          "offsetDuration": {
            "value": 5,
            "unit": "years",
            "system": "http://unitsofmeasure.org",
            "code": "a"
          },
          "text": "at 5 years"
        }
      ]
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2089-1",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma"
          }
        ]
      },
      "valueQuantity": {
        "value": 100,
        "comparator": "<",
        "unit": "mg/dL",
        "system": "http://unitsofmeasure.org",
        "code": "mg/dL"
      },
      "exclude": false,
      "description": "low-density lipoprotein cholesterol less than 100 mg/dL",
      "timing": [
        {
          "contextCode": {
            "coding": [
              {
                "system": "http://snomed.info/sct",
                "code": "709491003",
                "display": "Enrollment in clinical trial"
              }
            ]
          },
          "offsetDuration": {
            "value": 5,
            "unit": "years",
            "system": "http://unitsofmeasure.org",
            "code": "a"
          },
          "text": "at 5 years"
        }
      ]
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "8480-6",
            "display": "Systolic blood pressure"
          }
        ]
      },
      "valueQuantity": {
        "value": 130,
        "comparator": "<",
        "unit": "mm Hg",
        "system": "http://unitsofmeasure.org",
        "code": "mm[Hg]"
      },
      "exclude": false,
      "description": "systolic blood pressure less than 130 mm Hg",
      "timing": [
        {
          "contextCode": {
            "coding": [
              {
                "system": "http://snomed.info/sct",
                "code": "709491003",
                "display": "Enrollment in clinical trial"
              }
            ]
          },
          "offsetDuration": {
            "value": 5,
            "unit": "years",
            "system": "http://unitsofmeasure.org",
            "code": "a"
          },
          "text": "at 5 years"
        }
      ]
    }
  ]
}